PMID: 20647687Jul 22, 2010Paper

Dilazep decreases lipopolysaccharide-induced nitric oxide and TNF-alpha synthesis in RAW 264 cells

Journal of Pharmacological Sciences
Ryusuke NakatsukaKiyoshi Ohura

Abstract

Dilazep dihydrochloride (dilazep) is used to treat ischemic dysfunction, although the mechanisms underlying the anti-inflammatory effects of the drug have not yet been elucidated. The present study evaluated the anti-inflammatory effect of dilazep. Dilazep suppressed the production of nitric oxide (NO) and the expression of TNF-alpha mRNA by lipopolysaccharide (LPS) in RAW 264 cells. However, 1400W, an inducible NO synthase inhibitor, suppressed the production of NO but did not suppress the expression of TNF-alpha mRNA following treatment with LPS. Caffeine, an adenosine antagonist, restored LPS-stimulated NO synthesis, which is suppressed by dilazep. Therefore, these observations may suggest that the suppression of NO synthesis after dilazep treatment in RAW 264 cells is caused by the inhibition of TNF-alpha expression via adenosine receptors.

References

Sep 4, 1999·Japanese Circulation Journal·M KitakazeM Hori
Jan 20, 2006·American Journal of Physiology. Cell Physiology·Thomas J WeberBrian D Thrall
Apr 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Arvand HaschemiLeo E Otterbein
Dec 3, 2008·Pediatric Research·Raul Chavez-ValdezEstelle B Gauda
Jul 30, 2009·Handbook of Experimental Pharmacology·Michael R BlackburnConstance N Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.